￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Will dabrafenib be included in medical insurance reimbursement after it is launched?

2026-02-01 22:25:32

Check Details
What is the real efficacy of the new anti-lung cancer drug Osimertinib?

2026-02-01 22:25:32

Check Details
Will platelets drop after stopping eltrombopag?

2026-02-01 22:25:32

Check Details
Chinese drug instructions for use of Roprostim/Romigrastim

2026-02-01 22:25:32

Check Details
Disease control rate with axitinib/axitinib treatment

2026-02-01 22:25:32

Check Details
Analysis of the advantages and disadvantages of trametinib compared with chemotherapy regimens

2026-02-01 22:25:32

Check Details
Instructions for trametinib combined with dabrafenib in the treatment of BRAF V600 mutated cancer and price analysis of each version

2026-02-01 22:25:32

Check Details
Avatrombopag receives FDA approval to treat pediatric patients with chronic immune thrombocytopenia

2026-02-01 22:25:32

Check Details
FLT3-ITD MRD may guide Gilteritinib maintenance therapy after AML HCT

2026-02-01 22:25:32

Check Details
It is most appropriate to take several courses of Midostaurin

2026-02-01 22:25:32

Check Details
Full analysis of the effects and effects of cabergoline

2026-02-01 22:25:32

Check Details
Data shows momelotinib benefits anemia, reduces transfusion burden in myelofibrosis

2026-02-01 22:25:32

Check Details
Category
相关知识